SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-056486
Filing Date
2021-11-12
Accepted
2021-11-12 08:05:28
Documents
14
Period of Report
2021-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dice-8k_20211112.htm   iXBRL 8-K 39107
2 EX-99.1 dice-ex991_6.htm EX-99.1 128685
3 GRAPHIC g5kyfkb0jo4w000001.jpg GRAPHIC 12129
  Complete submission text file 0001564590-21-056486.txt   328757

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dice-20211112.xsd EX-101.SCH 5717
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dice-20211112_lab.xml EX-101.LAB 20093
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dice-20211112_pre.xml EX-101.PRE 11958
7 EXTRACTED XBRL INSTANCE DOCUMENT dice-8k_20211112_htm.xml XML 3690
Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40794 | Film No.: 211399750
SIC: 2834 Pharmaceutical Preparations